DPP9 and acute myeloid leukemia: Addressing this and other questions will shed additional light on NLRP1- and CARD8-mediated inflammasome activation, and aid translational work to target DPP8/DPP9 protease activity in AML and NLRP1-mediated skin dyskeratosis syndromes.